A Belgian Randomized Trial in Hepatitis C Virus-Infected Patients with Persistently Normal Alanine Aminotransferase

• Egile Nagusiak: Okyay Elkilic (Egilea), Philippe Langlet (Egilea), Michael Adler (Egilea), Chantal De Galocsy (Egilea), Isabelle Colle (Egilea), An Reekmans (Egilea), JeanPierre Mulkay (Egilea), Hans Van Vlierberghe (Egilea), Nathalie Boon (Egilea), Geert Robaeys (Egilea), Luc Lasser (Egilea)
• Formatua: Liburua
• Argitaratua: Global Journal of Clinical Virology - Peertechz Publications, 2016-10-15.
• Gaiak: Research Article
• Sarrera elektronikoa: Connect to this object online.

<p>Persistently normal alanine aminotransferase (PNALT) is present in 30 to 40% of chronic hepatitis patients and it is generally accepted that they have no liver damage. However, some studies suggest that there are some degrees of mild to moderate histological liver damage. We evaluated the f...